Astronics Corporation
ATROB
$21.25
$1.386.95%
| Weiss Ratings | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.73 | |||
| Price History | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 12.43% | |||
| 30-Day Total Return | 25.37% | |||
| 60-Day Total Return | 14.74% | |||
| 90-Day Total Return | 21.85% | |||
| Year to Date Total Return | 21.85% | |||
| 1-Year Total Return | 20.26% | |||
| 2-Year Total Return | 99.72% | |||
| 3-Year Total Return | 31.58% | |||
| 5-Year Total Return | -50.23% | |||
| 52-Week High % Change | -4.96% | |||
| 52-Week Low % Change | 57.41% | |||
| Price | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $22.36 | |||
| 52-Week Low Price | $13.50 | |||
| 52-Week Low Price (Date) | Apr 01, 2024 | |||
| 52-Week High Price (Date) | Jul 19, 2023 | |||
| Valuation | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 740.97M | |||
| Enterprise Value | 926.84M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.78 | |||
| Earnings Per Share Growth | -32.64% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.03 | |||
| Price/Book (Q) | 2.94 | |||
| Enterprise Value/Revenue (TTM) | 1.29 | |||
| Price | $21.25 | |||
| Enterprise Value/EBITDA (TTM) | 45.49 | |||
| Enterprise Value/EBIT | -171.80 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 34.86M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 716 805 1599 | |||
| Address | 130 Commerce Way East Aurora, NY 14052 | |||
| Website | www.astronics.com | |||
| Country | United States | |||
| Year Founded | 1968 | |||
| Profitability | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -0.75% | |||
| Profit Margin | -3.50% | |||
| Management Effectiveness | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.54% | |||
| Return on Equity | -- | |||
| Income Statement | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 717.74M | |||
| Total Revenue (TTM) | 717.74M | |||
| Revenue Per Share | $20.59 | |||
| Gross Profit (TTM) | 127.48M | |||
| EBITDA (TTM) | 20.38M | |||
| EBIT (TTM) | -5.40M | |||
| Net Income (TTM) | -25.18M | |||
| Net Income Avl. to Common (TTM) | -25.18M | |||
| Total Revenue Growth (Q YOY) | 18.23% | |||
| Earnings Growth (Q YOY) | 28.02% | |||
| EPS Diluted (TTM) | -0.78 | |||
| EPS Diluted Growth (Q YOY) | 34.86% | |||
| Balance Sheet | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 5.31M | |||
| Cash Per Share (Q) | $0.15 | |||
| Total Current Assets (Q) | 391.89M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 251.72M | |||
| Current Ratio (Q) | 2.591 | |||
| Book Value Per Share (Q) | $7.22 | |||
| Total Assets (Q) | 629.96M | |||
| Total Current Liabilities (Q) | 151.28M | |||
| Total Debt (Q) | 191.18M | |||
| Total Liabilities (Q) | 378.24M | |||
| Total Common Equity (Q) | 251.72M | |||
| Cash Flow | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -7.57M | |||
| Cash from Financing (TTM) | 11.22M | |||
| Net Change in Cash (TTM) | 893.00K | |||
| Levered Free Cash Flow (TTM) | 2.62M | |||
| Cash from Operations (TTM) | -2.73M | |||
